Received Dec 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | — | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | — | — |
to receive a revaccination with MMR II due to low titers after being fully vaccinated; This Spontaneous report was received from other health professional (medical assistant) and referred to a child patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant medications were not reported. On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live lyophilizate (M-M-R II) (0.50 mL; formulation, strength, route, lot number and expiration date were not reported) two dose series for prophylaxis. The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot # and expiration date were not reported). The patient came to their facility to receive a revaccination with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live lyophilizate (M-M-R II) due to low titers on an unknown date after being fully vaccinated (antibody test negative). The outcome of antibody test negative was not reported. The action taken with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live lyophilizate (M-M-R II) and sterile diluent (Hollister-Stier STERILE DILUENT) was not applicable. The causality between the event antibody test negative, measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live lyophilizate (M-M-R II) and sterile diluent (Hollister-Stier STERILE DILUENT) was not reported. Lot # is being requested and will be submitted if received.
sterile diluent
Test Name: antibody test; Result Unstructured Data: low titers